Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Galapagos
Sort By
Newest First
1 / 1
1 / 1
Clinical Trials
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
Gilead Sciences
PR-M10-19-NI-017
Oct 11, 2019
Collaboration
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
Gilead Sciences
PR-M07-19-NI-046
Jul 18, 2019
